NEUROPLAST


Our Mission
stemcell1

It is Neuroplast BVs commitment to ensure that their lead therapeutic interventions are commercialized as soon as possible, to increase quality of life of the patients suffering debilitating neurodegenerative disorders including idiopathic, post-traumatic and ischemic neurodegenerative disorders without restorative therapeutic perspectives. Especially of interest are diseases such as traumatic spinal cord injury, parkinsonism, multiple sclerosis, amyotrophic lateral sclerosis and Ischemic stroke. Important within Neuroplast is to translate science into therapeutic strategies, which can be achieved realistically in time and gain life time for patients with a fatal and/or stark debilitating disease. Important within Neuroplast is to translate science into therapeutic strategies, which can be achieved realistically in time and gain life time for patients with a fatal and/or stark debilitating disease. Important are the commitment of science and the authorization of the EMA/FDA for their products.

map

Neuroplast BV
Oxfordlaan 55
6229 EV Maastricht
The Netherlands
Phone: +31(0)433885617
Fax: +31(0)847399358
CoC-number: 61358827